Characterization of one anastomosis gastric bypass and impact of biliary and common limbs on bile acid and postprandial glucose metabolism in a minipig model.


Journal

American journal of physiology. Endocrinology and metabolism
ISSN: 1522-1555
Titre abrégé: Am J Physiol Endocrinol Metab
Pays: United States
ID NLM: 100901226

Informations de publication

Date de publication:
01 04 2021
Historique:
pubmed: 26 1 2021
medline: 25 5 2021
entrez: 25 1 2021
Statut: ppublish

Résumé

The alimentary limb has been proposed to be a key driver of the weight-loss-independent metabolic improvements that occur upon bariatric surgery. However, the one anastomosis gastric bypass (OAGB) procedure, consisting of one long biliary limb and a short common limb, induces similar beneficial metabolic effects compared to Roux-en-Y Gastric Bypass (RYGB) in humans, despite the lack of an alimentary limb. The aim of this study was to assess the role of the length of biliary and common limbs in the weight loss and metabolic effects that occur upon OAGB. OAGB and sham surgery, with or without modifications of the length of either the biliary limb or the common limb, were performed in Gottingen minipigs. Weight loss, metabolic changes, and the effects on plasma and intestinal bile acids (BAs) were assessed 15 days after surgery. OAGB significantly decreased body weight, improved glucose homeostasis, increased postprandial GLP-1 and fasting plasma BAs, and qualitatively changed the intestinal BA species composition. Resection of the biliary limb prevented the body weight loss effects of OAGB and attenuated the postprandial GLP-1 increase. Improvements in glucose homeostasis along with changes in plasma and intestinal BAs occurred after OAGB regardless of the biliary limb length. Resection of only the common limb reproduced the glucose homeostasis effects and the changes in intestinal BAs. Our results suggest that the changes in glucose metabolism and BAs after OAGB are mainly mediated by the length of the common limb, whereas the length of the biliary limb contributes to body weight loss.

Identifiants

pubmed: 33491532
doi: 10.1152/ajpendo.00356.2020
pmc: PMC8906817
doi:

Substances chimiques

Bile Acids and Salts 0
Blood Glucose 0
Glucose IY9XDZ35W2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

E772-E783

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK067561
Pays : United States

Références

Ann Surg. 2008 Jun;247(6):1074-5
pubmed: 18520238
Eur Surg Res. 2014;52(1-2):41-9
pubmed: 24557358
Cell Metab. 2019 Nov 5;30(5):852-854
pubmed: 31693881
Obes Surg. 2017 May;27(5):1153-1167
pubmed: 27783366
Ann Anat. 2019 May;223:1-7
pubmed: 30721719
Int J Obes (Lond). 2017 Apr;41(4):664-668
pubmed: 28093571
Nat Commun. 2015 Jul 02;6:7629
pubmed: 26134028
Drug Metab Dispos. 2008 Oct;36(10):1983-91
pubmed: 18583509
Ann Surg. 2005 Jul;242(1):20-8
pubmed: 15973097
Obes Surg. 2019 Aug;29(8):2367-2372
pubmed: 31104282
Clin Chem. 1979 Aug;25(8):1440-3
pubmed: 455682
Surg Endosc. 2019 Feb;33(2):401-410
pubmed: 29943058
Obes Surg. 2016 Mar;26(3):660-71
pubmed: 26749410
Surg Endosc. 2018 Mar;32(3):1382-1388
pubmed: 28840338
Gastroenterology. 2016 Feb;150(2):454-64.e9
pubmed: 26481855
Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):727-40
pubmed: 25194186
Int J Obes (Lond). 2016 Aug;40(8):1260-7
pubmed: 27089995
Obes Surg. 2019 Jun;29(6):1714-1720
pubmed: 30706320
Obes Surg. 2017 Sep;27(9):2293-2302
pubmed: 28405877
Cell Metab. 2019 Nov 5;30(5):855-864.e3
pubmed: 31588013
Gastroenterology. 2017 May;152(7):1679-1694.e3
pubmed: 28214524
Metabolism. 2020 Feb;103:154042
pubmed: 31785259
Mol Pharm. 2018 Jul 2;15(7):2621-2632
pubmed: 29792708
Obes Surg. 2001 Jun;11(3):276-80
pubmed: 11433900
Obes Surg. 2014 Oct;24(10):1595-602
pubmed: 24744188
Obes Surg. 2014 Sep;24(9):1536-51
pubmed: 25001288
Gastroenterology. 2019 Mar;156(4):1041-1051.e4
pubmed: 30445014
JAMA. 1976 Nov 15;236(20):2298-301
pubmed: 989831
Front Endocrinol (Lausanne). 2018 Sep 10;9:530
pubmed: 30250454
J Clin Endocrinol Metab. 2008 Jul;93(7):2479-85
pubmed: 18430778
Int J Obes (Lond). 2015 May;39(5):806-13
pubmed: 25599611
PLoS One. 2010 Nov 11;5(11):e13953
pubmed: 21085649
Cell Metab. 2016 Mar 8;23(3):547-53
pubmed: 26924216
J Clin Endocrinol Metab. 2010 Aug;95(8):4072-6
pubmed: 20501690
Lancet. 2014 Aug 30;384(9945):766-81
pubmed: 24880830
Science. 2013 Jul 26;341(6144):406-10
pubmed: 23888041
J Clin Endocrinol Metab. 2014 Apr;99(4):1442-51
pubmed: 24432996
Surg Obes Relat Dis. 2008 Jul-Aug;4(4):521-5; discussion 526-7
pubmed: 18539540
Nature. 2012 Sep 13;489(7415):242-9
pubmed: 22972297
Surg Obes Relat Dis. 2019 Apr;15(4):643-649
pubmed: 30773442
Int J Surg Case Rep. 2017;33:71-74
pubmed: 28282599
Br J Pharmacol. 2011 Jul;163(5):937-47
pubmed: 21323901
Nat Med. 2012 Jun;18(6):950-5
pubmed: 22610279
Lancet. 2019 Mar 30;393(10178):1299-1309
pubmed: 30851879
Gastroenterology. 2014 Mar;146(3):669-680.e2
pubmed: 24315990
Can J Diabetes. 2017 Aug;41(4):439-447
pubmed: 28552651
J Biol Chem. 1988 Nov 15;263(32):16637-44
pubmed: 3182806
Int J Mol Med. 2007 Nov;20(5):703-7
pubmed: 17912464
Gut. 2017 Feb;66(2):226-234
pubmed: 26511794
Surgery. 2016 May;159(5):1360-71
pubmed: 26767308
Ann Surg. 2009 Jun;249(6):948-53
pubmed: 19474685

Auteurs

Camille Marciniak (C)

U1190, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France.

Oscar Chávez-Talavera (O)

U1011, Institut Pasteur de Lille, University of Lille, Inserm Lille, France.

Robert Caiazzo (R)

U1190, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France.

Thomas Hubert (T)

U1190, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France.

Lorea Zubiaga (L)

U1190, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France.

Gregory Baud (G)

U1190, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France.

Audrey Quenon (A)

U1190, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France.

Amandine Descat (A)

Mass Spectrometry Department, Pharmacy Faculty, PSM-GRITA, Lille, France.

Emmanuelle Vallez (E)

U1011, Institut Pasteur de Lille, University of Lille, Inserm Lille, France.

Jean François Goossens (JF)

Mass Spectrometry Department, Pharmacy Faculty, PSM-GRITA, Lille, France.

Mostafa Kouach (M)

Mass Spectrometry Department, Pharmacy Faculty, PSM-GRITA, Lille, France.

Vincent Vangelder (V)

U1190, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France.

Mathilde Gobert (M)

U1190, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France.

Mehdi Daoudi (M)

U1190, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France.

Bruno Derudas (B)

U1011, Institut Pasteur de Lille, University of Lille, Inserm Lille, France.

Pascal Pigny (P)

Mass Spectrometry Department, Pharmacy Faculty, PSM-GRITA, Lille, France.

André Klein (A)

Metabolism and Glycosylation Diseases, Biology Pathology Center, Lille, France.

Valéry Gmyr (V)

U1190, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France.

Violeta Raverdy (V)

U1190, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France.

Sophie Lestavel (S)

U1011, Institut Pasteur de Lille, University of Lille, Inserm Lille, France.

Blandine Laferrère (B)

Division of Endocrinology, Department of Medicine, New York Obesity Research Center, Columbia University Irving Medical Center, New York, New York.

Bart Staels (B)

U1011, Institut Pasteur de Lille, University of Lille, Inserm Lille, France.

Anne Tailleux (A)

U1011, Institut Pasteur de Lille, University of Lille, Inserm Lille, France.

François Pattou (F)

U1190, Institut Pasteur de Lille, University of Lille, Inserm, Lille, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH